Loading insider details...
Beta
Latest Form 4 (Sep 10, 2026): Sale of 358 MGX shares, $414.71.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 10, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 358 | $414.71 |
| Jun 10, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 558 | $724.84 |
| Apr 3, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Grant/Award | 11,000 | n/a |
| Mar 9, 2026 | Metagenomi Therapeutics, Inc. (MGX) | Sale | 482 | $771.20 |
| Dec 8, 2025 | Metagenomi, Inc. (MGX) | Sale | 199 | $352.61 |
| Dec 1, 2025 | Metagenomi, Inc. (MGX) | Sale | 199 | $360.19 |
| Jun 9, 2025 | Metagenomi, Inc. (MGX) | Sale | 199 | $348.25 |
| Apr 3, 2025 | Metagenomi, Inc. (MGX) | Grant/Award | 3,650 | n/a |
| Mar 7, 2025 | Metagenomi, Inc. (MGX) | Sale | 930 | $1.7K |
| Apr 4, 2024 | Metagenomi, Inc. (MGX) | Grant/Award | 10,397 | n/a |